 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Covance teams up with Tempus with time on its mind
- badams
- Wed, 09/16/2020 - 09:48...


Covance teams up with Tempus with time on its mind

---
- Clinical lab titan LabCorp Diagnostics announced that its contract research organization
  (CRO), Covance, will partner with digital clinical trial software maker Medable
  to allow clinical trial participants to engage with trials remotely to help reduce
  patient drop-offs spurred by the pandemic.


LabCorp teamed up with Medable to enable clinical trial participants to engage remotely

---
- Never before has the need to accelerate the clinical trial process been more paramount
  than in the midst of a global pandemic. Since the domestic onset of Covid-19, LabCorp,
  the Burlington-based life sciences corporation, has been working to aid in the fight
  against the delay virus by conducting diagnostics and developing and deploying test
  kist for firs responders and frontline workers.


LabCorp affiliate to expand, expedite virtual clinical trials

---
- LabCorp has unveiled a new suite of cell and gene therapy development offerings
  from Covance as it looks to get in on this burgeoning new trend. "These solutions
  are designed to reduce time and risk for sponsors at each phase and across the full
  continuum of their therapy development needs in one of the industry's fastest-growing
  segments," Covance, the CRO unit of diagnostics giant LabCorp, said in a statement.


LabCorp's CRO unit Covance doubles down on cell, gene therapy offerings

---
- John Ratliff's position has changed three times this fall, but now, much like the
  falling leaves, he looks to have settled. The former chief at major CRO Covance
  (now owned by LabCorp), Ratliff was announced back in October amid a raft of changes
  that he would be leaving his former post and moving up to lead LabCorp Diagnostics.


From Covance CEO to short-lived LabCorp diagnostics lead, Ratliff lands at AMRI

Covance clinical development lead takes the reins at Pharm-Olam

---
- LabCorp's CRO business Covance will boost its nonclinical contract research services
  business as its parent company buys out the segment from Envigo, while the latter
  repositions. On the flip side of this deal, Envigo's Research Models Services business
  will buy up Covance's Research Products business.


Market Cap	$0.00
52-Wk High	$18.90
52-Wk Low	$17.11

CVD Covance Inc.

About

Feed

News

Fundamentals